References
Dotter CT, Judkins MP (1964) Transluminal treatment of arteriosclerotic obstructions: Description of a new technique and a preliminary report of its application. Circulation 30:654–670
Zeitler E, Schoop W, Zahnow W (1971) The treatment of occlusive arterial disease by transluminal catheter angioplasty. Radiology 99: 19–26
Gruentzig A, Hopff H (1974) Percutaneous recanalization after chronic arterial occlusions with a new dilator-catheter. Dtsch Med Wochenschr 99:2502–2510
Olbert F, Hanecka L (1977) Transluminal blood vessel dilatation by means of a modified dilatation catheter. Fortschr Med 95:867–869
Castañeda-Zũniga WR, Formanek A, Tadavarthy M, Vlodaver Z, Edwards JF, Zollikofer C, Amplatz K (1980) The mechanism of balloon angioplasty. Radiology 135:565–571
Zollikofer CL, Salomonowitz E, Sibley R, Chain J, Bruehlmann WF, Castañeda-Zúñiga WR, Amplatz K (1984) Transluminal angioplasty evaluated by electron microscopy. Radiology 153:369–374
Lyon RT, Zarins CK, Lu CT, Yang CF, Glagov S (1987) Vessel, plaque, and lumen morphology after transluminal balloon angioplasty: Quantitative study in distended human arteries. Arteriosclerosis 7:306–314
Schwartz RS (1997) The vessel wall reaction in restenosis. Semin Interv Cardiol 2:83–88
Wilensky RL, March KL, Gradus-Pizlo I, Sandurky G, Fineberg N, Hathaway DR (1995) Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit. Circulation 92:2995–3005
Di Mario C, Gil R, Camenzind E, Ozaki Y, von Birgelen C, Umans V, de Jaegere P, de Feyter PJ, Roelandt JR, Serruys PW (1995) Quantitative assessment with intracoronary ultrasound of the mechanisms of restenosis after percutaneous transluminal coronary angioplasty and directional coronary atherectomy. Am J Cardiol 75:772–777
Mintz GS, Popma J, Pichard AD, Kent KM, Satler LF, Wong C, Hong MK, Kovach JA, Leon MB (1996) Arterial remodelling after coronary angioplasty: A serial intravascular ultrasound study. Circulation 94: 35–43
Pasterkamp G, Wensing PJ, Post MJ, Hillen B, Mali WP, Borst C (1995) Paradoxical arterial wall shrinkage may contribute to luminal narrowing of human atherosclerotic femoral arteries. Circulation 91: 1444–1449
Pasterkamp G, Hillen B, Borst C (1997) Arterial remodelling by atherosclerosis. Semin Interv Cardiol 2:147–152
Lafont A, Moreyra C, Grati Z, Durand E, Bougrini K, Rahal S, Desnos M, Guerot C (1997) Compensatory enlargement versus chronic constriction: The two features of vascular remodelling after experimental angioplasty. Arch Mal Coeur Vaiss 90:827–834
Palmaz JC, Sibbitt RR, Reuter SR, Tio FO, Rice WJ (1985) Expandable intraluminal graft: A preliminary study. Radiology 156:73–77
Palmaz JC (1993) Intravascular stents: Tissue-stent interactions and design considerations. AJR 160:613–618
Kearney M, Pieczek A, Haley L, Losordo DW, Andres V, Schainfeld R, Rosenfield K, Isner JM (1997) Histopathology of in-stent restenosis in patients with peripheral artery disease. Circulation 95:1998–2002
Barth KH, Virmani R, Froehlich J, Takeda T, Losset SV, Newsome J, Jones R, Lindisch D (1996) Paired comparison of vascular wall reactions to Palmaz stents, Strecker tantalum stents, and Wallstents in canine iliac and femoral arteries. Circulation 93:2161–2169
Richter GM, Palmaz JC, Noeldge G, Tio F (1999) Relationship between blood flow, thrombus, and neointima in stents. J Vasc Interv Radiol 10:598–604
Clowes AW, Kirkman TR, Clowes MM (1986) Mechanisms of arterial graft failure. II. Chronic endothelial and smooth muscle cell proliferation in healing polytetrafluoroethylene prostheses. J Vasc Surg 3:877–884
Golden MA, Hanson SR, Kirkman TR, Schneider PA, Clowes AW (1990) Healing of polytetrafluoroethylene arterial grafts is influenced by graft porosity. J Vasc Surg 11:838–845
Dolmatch BL, Tio FO, Li XD, Dong YH (1996) Patency and tissue response related to two types of polytetrafluoroethylene-covered stents in the dog. J Vasc Interv Radiol 7:641–649
Cejna M, Virmani R, Jones R, Bergmeister H, Losert V, Xu Z, Yang P, Schoder M, Lammer J (2001) Biocompatibility and performance of different types of covered stents in the sheep model. J Vasc Interv Radiol (in press)
Virmani R, Kolodgie FD, Dake MD, Silver JH, Jones RM, Jenkins M, Gillespie DL (1999) Histopathologic evaluation of an expanded polytetrafluoroethylene-nitinol stent endoprosthesis in canine iliofemoral arteries. J Vasc Interv Radiol 10:445–456
Marin J, Veith F, Cynamon J, Sanchez LA, Bakal CW, Suggs WD, Lyon RT, Schwartz ML, Parsons RE, Wengerter KR (1995) Human transluminally placed endovascular stented grafts: Preliminary histopathologic analysis of healing grafts in aortoiliac and femoral artery occlusive disease. J Vasc Surg 21:595–604
Marin J, Veith F, Cynamon J, Parsons RE, Lyon RT, Suggs WD, Bakal CW, Waahl S, Sanchez LA, Yuan JG, Ohki T (1996) Effect of polytetrafluoroethylene covering of Palmaz stents on the development of intimal hyperplasia in human iliac arteries. J Vasc Interv Radiol 7:651–656
Fontaine R, Kim M, Kieny R (1954) Die chirurgische Behandlung der peripheren Durchblutungsstörung. Helv Chir Acta 5/6:199-233
Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN (1997) Recommended standards for reports dealing with lower extremity ischemia: Revised version. J Vasc Surg 26:517–538
Antiplatelet Trialists Collaboration (1988) Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ 296:320–331
Goldhaber SZ, Manson JE, Stampfer MJ, LaMotte F, Rosner B, Buring JE, Hennekens CH (1992) Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians Health Study. Lancet 340:143–145
Janzon L, Berqvist D, Boberg J, Boberg M, Eriksson I, Lindgarde F, Persson G, Almgren B, Fagher B, Kjellstrom T, et al. (1990) Prevention of myocardial infarction and stroke in patients with intermittent claudication: Effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicenter Study. J Intern Med 227:301–308
CAPRIE Steering Committee (1996) A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet 348:1329–1339
Regensteiner JG, Meyer TJ, Krupsky WC, Cranford LS, Hiatt WR (1997) Hospital vs home based exercise rehabilitation for patients with peripheral arterial occlusive disease. Angiology 48:291–300
Hiatt WR, Regensteiner JG, Hargarten ME, Wolfel EE, Brass EP (1990) Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation 81:602–609
Hiatt WR, Wolfel EE, Meier RH, Regensteiner JG (1994) Superiority of treadmill walking exercise vs strength training for patients with peripheral arterial disease. Circulation 90:1866–1874
Creasy TS, McMillan PJ, Fletcher EWL, Collin J, Morris PJ (1990) Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomized trial. Eur J Vasc Surg 4:135–140
Gardner AW, Poehlman ET (1995) Exercise rehabilitation programs for the treatment of claudication pain: A meta-analysis. JAMA 274: 975–980
Patterson RB, Pinto B, Marcus B, Colucci A, Braun T, Roberts M (1997) Value of a supervised exercise program for the therapy of arterial claudication. J Vasc Surg 25:312–318
Waugh JR (1992) Arteriographic complications in the DSA era. Radiology 182:243–246
Elsman BH (1995) Impact of ultrasonographic duplex scanning on therapeutic decision making in lower-limb arterial disease. Br J Surg 82:630–633
Elsman BH (1996) The use of color-coded duplex scanning in the selection of patients with lower extremity arterial disease for percutaneous transluminal angioplasty: A prospective study. Cardiovasc Intervent Radiol 19:313–316
Kohler TR, Andros G, Porter JM, Clowes A, Goldstone J, Johansen K, Raker E, Nance DR, Strandness DE Jr (1989) Can duplex scanning replace arteriography for lower extremity arterial disease? Ann Vasc Surg 4:280–287
Legemate DA, Teeuwen C, Hoeneveld H, Ackerstaff RG, Eikelboom BC (1989) The potential for duplex scanning to replace aorto-iliac and femoral popliteal arteriography. Eur Vasc Surg 3:49–54
Hany TF, Debatin JF, Leung DA, Pfamatter T (1997) Evaluation of the aortoiliac and renal arteries: Comparison of breath-hold, contrastenhanced, three-dimensional MR angiography with conventional catheter angiography. Radiology 204:357–362
Poon E, Yucel EK, Pagan-Marin H, Kayne H (1997) Iliac artery stenosis measurements: Comparison of two-dimensional time-of-flight and three-dimensional dynamic gadolinium-enhanced MR angiography. AJR 169:1139–1144
Ho KY, Leiner T, de Haan MW, Kessels AG, Kitslaar PJ, van Engelshoven JM (1998) Peripheral vascular tree stenoses: Evaluation with moving-bed infusion-tracking MR angiography. Radiology 206: 683–692
Cambria RP, Kaufman JA, L’Italien GJ, Gertler JP, LaMuraglia GM, Brewster DC, Geller S, Atamian S, Waltman AC, Abbott WM (1997) Magnetic resonance angiography in the management of lower extremity arterial occlusive disease: A prospective study. J Vasc Surg 25: 380–389
Quinn SF, Sheley RC, Semonsen KG, Leonardo VJ, Kojima K, Szumowski J (1998) Aortic and lower-extremity arterial disease: Evaluation with MR angiography versus conventional angiography. Radiology 206:693–701
Hoch JR, Tullis MJ, Kennell TW, McDermott J, Acher CW, Turnipseed WD (1996) Use of magnetic resonance angiography for the preoperative evaluation of patients with infrainguinal arterial occlusive disease. J Vasc Surg 23:792–800
Rofsky NM, Adelman MA (2000) MR angiography in the evaluation of atherosclerotic peripheral vascular disease. Radiology 214:325–338
Huber TS, Back MR, Ballinger RJ, Culp WC, Flynn TC, Kubilis PS, Seeger JM (1997) Utility of magnetic resonance arteriography for distal lower extremity revascularization. J Vasc Surg 26:415–423
Whyman MR, Fowkes FG, Kerracher EM, Gillespie IN, Lee AJ, Housley E, Ruckley CV (1997) Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. J Vasc Surg 26:551–557
Pentecost MJ, Criqui MH, Dorros G, Goldstone J, Johnston KW, Martin EC, Ring EJ, Spies JB (1994) Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. Circulation 89:511–531
Standards of Practice Committee of the Society of Cardiovascular and Interventional Radiology (1992) Angioplasty standard of practice. J Vasc Interv Radiol 3:269–271
TASC (2000) TransAtlantic InterSociety Consensus (TASC) document on management of peripheral arterial disease. J Vasc Surg 31:S1–S296
Bolia A, Miles KA, Brennan J, Bell PR (1990) Percutaneous transluminal angioplasty of occlusions of the femoral and popliteal arteries by subintimal dissection. Cardiovasc Intervent Radiol 13:357–363
London NJ, Srinivasan R, Naylor AR, Hartshome T, Ratliff DA, Bell PR, Bolia A (1994) Subintimal angioplasty of femoropopliteal artery occlusions: The long-term results. Eur J Vasc Surg 8:148–155
Bonn J (1996) Percutaneous vascular interventions: Value of hemodynamic measurements. Radiology 201:18–20
Rosenfield K, Schainfeld R, Pieczek A, Haley L, Isner JM (1997) Restenosis of endovascular stents from stent compression. J Am Coll Cardiol 29:328–338
Lammer J, Dake MD, Bleyn J, Katzen BT, Cejna M, Piquet P, Becker GJ, Settlage RA (2000) Peripheral arterial obstruction: Prospective study of a treatment with transluminally placed self-expanding stent-graft. Radiology 217:95–104
Gardiner GA, Meyerovitz MF, Stokes KR, Clouse ME, Harrington DP, Bettmann MA (1986) Complications of transluminal angioplasty. Radiology 159:201–208
Duda SH, Wiskirchen J, Erb M, Schott U, Khaligi K, Pereira PL, Albes J, Claussen CD (1999) Suture-mediated percutaneous closure of antegrade femoral arterial access sites in patients who have received full anticoagulation therapy. Radiology 210:47–52
Heiss HW, Just H, Middleton D, Deichsel G (1990) Reocclusion prophylaxis with dipyridamole combined with acetylsalicylic acid following PTA. Angiology 41:263–269
Study Group on Pharmacological Treatment after PTA (1994) Platelet inhibition with ASA/dipyridamole after percutaneous balloon angioplasty in patients with symptomatic lower limb arterial disease: A prospective double-blind trial. Eur J Vasc Surg 8:83–88
Minar E, Ahmadi A, Koppensteiner R, Maca T, Stumpflen A, Ugurluoglu A, Ehringer H (1995) Comparison of effects of high-dose and low-dose aspirin on restenosis after femoropopliteal percutaneous transluminal angioplasty. Circulation 91:2167–2173
Herbert JM, Dol F, Bernat A, Falotico R, Lale A, Savi P (1998) The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit. Thromb Haemost 80:512–518
Leon MN, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK, Giambartolomei A, Diver DJ, Lasorda DM, Williams DO, Pocock SJ, Kuntz RE (1998) A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting: Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 339:1665–1675
Rupprecht HJ, Darius H, Borkowski U, Voigtlander T, Nowak B, Genth S, Meyer J (1998) Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation. Circulation 97:1046–1052
Moussa I, Oetgen M, Roubin G, Colombo A, Wang X, Iyer S, Maida R, Collins M, Kreps E, Moses JW (1999) Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. Circulation 99:2364–2366
Criqui MH, Fronek A, Klauber MR, Barrett-Connor E, Gabriel S (1985) The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: Results from non-invasive testing of a defined population. Circulation 71:516–522
Applegate WB (1993) Ankle—arm blood pressure index: A useful test for clinical practice? JAMA 270:487–489
Ware JE, Sherbourne CD (1992) The MOS 36-item short form health survey (SF36): Conceptual framework and item selection. Med Care 30:473–483
Gallino A, Mahler F, Probst P, Nachbur B (1984) Percutaneous transluminal angioplasty of the arteries of the lower limbs: A 5 year follow-up. Circulation 70:619–623
Krepel VM, van Andel GJ, van Erp WF, Breslau PJ (1985) Percutaneous transluminal angioplasty of the femoropopliteal artery: Initial and long term results. Radiology 156:325–328
Jeans WD, Armstrong S, Cole SEA, Horrocks M, Baird RN (1990) Fate of patients undergoing transluminal angioplasty for lower-limb ischemia. Radiology 177:559–564
Capek P, McLean GK, Berkowitz HD (1991) Femoropopliteal angioplasty: Factors influencing long-term success. Circulation 83:70–80
Johnston KW (1992) Femoral and popliteal arteries: Reanalysis of results of balloon angioplasty. Radiology 183:767–771
Hunink MGM, Wong JB, Donaldson MC, Meyerovitz MF, de Vries J, Harrington DP (1995) Revascularization of femoropopliteal artery disease: A decision and cost effective analysis. JAMA 274:165–171
Matsi PJ, Manninen HI, Vanninen RL, Suhonen MT, Oksala I, Laakso M, Hakkarainen T, Soimakallio S (1994) Femoropopliteal angioplasty in patients with claudication: Primary and secondary patency in 140 limbs with 1–3 year follow-up. Radiology 191:727–733
Murray JG, Apthorp LA, Wilkins RA (1995) Long-segment (>10 cm) femoropopliteal angioplasty: Improved techical success and long-term patency. Radiology 195:158–162
Lammer J, Pilger E, Decrinis M, Quehenberger F, Klein GE, Stark G (1992) Pulsed excimer laser versus continuous-wave Nd:YAG laser versus conventional angioplasty of peripheral arterial occlusions: Prospective, controlled, randomized trial. Lancet 340:1183–1188
Rousseau HP, Raillat CR, Joffre FG, Knight CJ, Ginestet MC (1989) Treatment of femoropopliteal stenoses by means of self-expandable endoprostheses: Midterm results. Radiology 172:961–964
Zollikofer CL, Antonucci F, Pfyffer M, Redha F, Salomonowitz E, Stuckmann G, Langiader I, Marty A (1991) Arterial stent placement with use of the Wallstent: Midterm results of clinical experience. Radiology 179:449–456
Do DD, Triller J, Walpoth BH, Stirnemann P, Mahler F (1992) A comparison study of self-expandable stents vs balloon angioplasty alone in femoropopliteal artery occlusions. Cardiovasc Intervent Radiol 15:306–312
Sapoval MR, Long AL, Raynaud AC, Beyssen BM, Fiessinger JN, Gaux JC (1992) Femoropopliteal stent placement: Long-term results. Radiology 184:833–839
Liermann D, Strecker EP, Peters J (1992) The Strecker stent: Indications and results in iliac and femoropopliteal arteries. Cardiovasc Intervent Radiol 15:298–305
Henry M, Amor M, Ethevenot G, Henry I, Amicabile C, Beron R, Mentre B, Allaoui M, Touchot N (1995) Palmaz stent placement in iliac and femoropopliteal arteries: Primary and secondary patency in 310 patients with 2–4 year follow-up. Radiology 197:167–174
Martin EC, Katzen BT, Benenati JF, Diethrich EB, Dorros G, Graor RA, Horton KM, Iannone LA, Isner JM (1995) Multicenter trial of the Wallstent in iliac and femoral arteries. J Vasc Interv Radiol 6:843–849
White GH, Liew SC, Waugh RC, Stephen MS, Harris JP, Kidd J, Sachinwalla T, Yu W, May J (1995) Early outcome and intermediate follow-up of vascular stents in the femoral and popliteal arteries without long-term anticoagulation. J Vasc Surg 21:270–279
Bray AE, Liu WG, Lewis WA, Harrison C, Maullin A (1995) Strecker stents in the femoropopliteal arteries: Value of duplex ultrasonography in restenosis assessment. J Endovasc Surg 2:150–160
Strecker EP, Boos IB, Gottmann D (1997) Femoropopliteal artery stent placement: Evaluation of long-term success. Radiology 205:375–383
Gray B, Sullivan TM, Childs MB, Young JR, Olin ZW (1997) High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg 25:74–83
Bergeron P, Pinot JJ, Poyen V, Benichou H, Khanoyan P, Rudondy P, Wang Y, Chiarandini S, el Hussein R, Rieu R, et al (1995) Long-term results with the Palmaz stent in the superficial femoral artery. J Endovasc Surg 2:161–167
Vroegindeweij D, Vos LD, Tielbeek AV, Buth J, van de Bosch HCM (1997) Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: A comparative randomized study. Cardiovasc Intervent Radiol 20:420–425
Cejna M, Thurnher S, Illiasch H, Horvath W, Waldenberger P, Hornick K, Lammer J (2001) Percutaneous transluminal angioplasty (PTA) versus Palmaz stent placement in femoropopliteal artery obstruction: A multicenter prospective randomized study. J Vasc Interv Radiol 12:23–31
Cragg AH, Dake MD (1993) Percutaneous femoropopliteal graft placement. Radiology 187:643–648
Cragg AH, Dake MD (1997) Treatment of peripheral vascular disease with stent-grafts. Radiology 205:307–314
Henry M, Amor M, Cragg A, Porte JM, Henry I, Amicabile C, Trichoche O (1996) Occlusive and aneurysmal peripheral arterial disease: Assessment of a stent-graft system. Radiology 201:717–724
Link J, Mueller-Huelsbeck S, Brossmann J, Steffens JC, Heller M (1996) Perivascular inflammatory reaction after percutaneous placement of covered stents. Cardiovasc Intervent Radiol 19:345–347
Maynar M, Reyes R, Ferral H, Gorriz E, Gomez-Toledo F, de Blas M, Huppert T, Castaneda-Zuniga WR (1997) Cragg Endopro-I: Early experience in femoral arteries. J Vasc Interv Radiol 8:203–207
Katzenschlager R, Ugurluoglu A, Ahmadi A, Hulsmann M, Koppensteiner R, Larch E, Maca T, Minar E, Stumpflen A, Ehringer H (1995) Incidence of pseudoaneurysm after diagnostic and therapeutic angiography. Radiology 195:463–466
Becker GJ, Katzen BT, Dake MD (1989) Noncoronary angioplasty. Radiology 170:921–940
Matsi PJ, Manninen HI (1998) Complications of lower limb percutaneous transluminal angioplasty: A prospective analysis of 410 procedures on 295 consecutive patients. Cardiovasc Intervent Radiol 21: 361–366
Currie IC, Wakeley CJ, Cole SE, Wyatt MG, Scott DJ, Baird RN, Horrocks (1994) Femoropopliteal angioplasty for severe limb ischemia. Br J Surg 81:191–193
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lammer, J. Femoropopliteal Artery Obstructions: From the Balloon to the Stent-Graft. Cardiovasc Intervent Radiol 24, 73–83 (2001). https://doi.org/10.1007/s002700001749
Published:
Issue Date:
DOI: https://doi.org/10.1007/s002700001749